New research finds that mortality among patients with idiopathic pulmonary arterial hypertension (IPAH) awaiting lung transplant has not decreased, despite implementation of a new allocation system. The study suggests that key prognostic indicators in IPAH are not adequately captured by the current LAS algorithm.
Severe COPD is associated with significantly lower cognitive function in older adults, even after controlling for confounding factors. Patients with severe COPD are at greater risk for developing cognitive impairment, which can worsen their general health and quality of life.
A study found that high soy intake was associated with improved lung function and a lower risk of developing chronic obstructive pulmonary disease (COPD) in smokers. Flavonoids in soy may help protect against tobacco carcinogens, but more research is needed to understand the underlying mechanism.
A study published in the New England Journal of Medicine suggests that cigarette smoking does not affect everyone in the same way, with some people experiencing severe breathing difficulties while others evade the disease. The research proposes an autoimmune mechanism compounded by genetic predisposition as a possible explanation for t...
A lifestyle modification program for patients with mild to moderate COPD significantly improves health status, exercise capacity, and quality of life over a 2-year period. The program is also found to be cost-effective, despite initial higher costs.
Researchers found that calcitriol, a form of vitamin D, reduced growth-factor-induced airway smooth muscle proliferation in cells isolated from both asthmatic and non-asthmatic individuals. This process, called airway remodeling, leads to reduced lung function over time if left untreated.
A pooled analysis of two studies found significant improvements in pulmonary function, dyspnea, and rescue medication use when Perforomist Inhalation Solution was added to maintenance tiotropium. Patient satisfaction also increased with twice-daily Perforomist Inhalation Solution compared to ipratropium/albuterol metered-dose inhaler.
A new study suggests that women may be more vulnerable to the harmful effects of smoking due to smaller airways and gender differences in metabolism. The research analyzed data from a Norwegian case-control study, including 954 subjects with chronic obstructive pulmonary disease (COPD) and 955 controls.
The COPD Foundation's new Lung Health Check platform offers a quick assessment of breathing problems and provides personalized reports with suggestions for prevention and management. The resource aims to inform, educate, and empower individuals to take control of their lung health.
Researchers found that a self-treatment program for COPD patients led to fewer exacerbation days and increased medication use. This resulted in cost savings due to reduced hospitalizations and healthcare contacts. The study suggested that implementing such programs could help manage COPD effectively.
Data from two presentations will feature Perforomist Inhalation Solution, showing improved pulmonary function and dyspnea in patients with COPD when added to maintenance tiotropium. Patient satisfaction also increased in those treated with Perforomist twice daily compared to ipratropium/albuterol MDI
Researchers link muscle decline to elevated carbon dioxide in blood of patients with lung diseases, discovering surprising effects including increased lifespan and dynamic gene changes. High CO2 levels may impact treatment strategies for lung conditions.
Smoking both marijuana and tobacco significantly increases respiratory symptoms and chronic obstructive pulmonary disease (COPD) risk. A study of 878 adults aged 40 or older found that those who smoked both substances were 2.5 times more likely to have respiratory symptoms and almost 3 times more likely to have COPD.
Researchers found that cigarette smoke exposure alters the immune response to bacteria in mice, leading to increased inflammation and weight loss. This shift in inflammatory markers may impact treatment efficacy with corticosteroids for COPD patients.
Pulmonary rehabilitation improves aerobic function, reducing breathlessness in COPD patients. Supervised exercise also decreases anxiety and depression by enabling patients to master new skills.
Patients with moderate to severe COPD show altered breathing and swallowing coordination even during normal eating. The study found that COPD patients swallow more often at the end of exhalation, a pattern that disrupts safe swallowing.
Scientists at Duke University Medical Center have discovered two genetic markers that significantly increase the risk of developing chronic obstructive pulmonary disease (COPD) in smokers. These variants, located near a nicotine receptor, may be reduced by quitting smoking before COPD symptoms appear.
Researchers at Boston University School of Medicine identified a gene variant on chromosome 4 associated with an increased risk of COPD. The study, conducted in collaboration with the Framingham Heart Study, found that genetic factors play a role in susceptibility to cigarette smoke and impaired lung function.
Researchers found five single nucleotide polymorphisms (SNPs) in ADAM33 that were more frequent in COPD patients than non-COPD smokers. These polymorphisms, particularly S1, are associated with lung abnormalities and progressive decline in lung function characteristic of COPD.
New research shows individual COPD exacerbations increase repeat likelihood, driving disease progression. Patients may be 'brittle' during a subsequent eight-week period, requiring close monitoring and follow-up to prevent further exacerbations.
New research finds that long-term use of inhaled corticosteroid drugs increases the risk of pneumonia in patients with Chronic Obstructive Pulmonary Disease (COPD). Analysis of 18 randomized clinical trials showed a significant association between corticosteroid inhaler use and pneumonia, with nearly one in every 47 patients developing...
A new study from the University of Cincinnati finds that cigarette smoke can activate specific immune system receptors, leading to worsening of chronic obstructive pulmonary disorder (COPD) symptoms. The research identified a key cellular receptor, NKG2D, involved in this process.
Researchers found that activating Nrf2 can prevent emphysema in mice by reducing oxidative stress and improving lung function. The study suggests targeting Nrf2 could be a novel strategy for preventing chronic obstructive pulmonary disease (COPD).
A study by Drs. François Maltais and Jean Bourbeau found that home-based pulmonary rehabilitation is as effective as hospital-based treatment in improving symptoms and quality of life for COPD patients. The program, which involves aerobic exercises, can be performed alone and has the potential to reduce healthcare costs.
A new study published in Annals of Internal Medicine finds that colonoscopy significantly reduces deaths from colorectal cancer due to left-sided cancers. However, the risk reduction is negligible for right-sided cancer. The study suggests that physicians should advise patients of the limitations of colonoscopy.
The study aims to develop an understanding of COPD pathogenesis and yield tools for stratifying and treating patients based on molecular processes. The research will help identify the molecular processes that give rise to disease-specific symptoms in individual patients.
Researchers found that inhaled corticosteroid drugs increase the risk of pneumonia by a full third in people with chronic obstructive pulmonary disease (COPD). The study suggests that the treatment may be more harmful and pose a greater risk to some individuals, particularly those with weakened immune systems.
A review of 11 randomized trials found no benefit in survival from inhaled corticosteroid therapy for stable COPD. However, the use of ICS was associated with a higher incidence of pneumonia in patients with COPD.
A year-long study found that long-term use of a macrolide antibiotic reduced COPD exacerbations by 35% in patients with moderate to severe disease. The treatment also decreased the severity and duration of exacerbations, but its benefits are offset by concerns about growing antibiotic resistance.
Researchers have shown that HRV hijacks many of your genes, leading to an overblown immune response. The study identifies novel candidate genes that could be targeted for drug development to treat colds and exacerbations of asthma and COPD.
Research suggests depression and anxiety can cause increased hospitalizations and exacerbations in COPD patients, with depressed individuals experiencing more symptom- and event-based exacerbations and longer hospital stays. Anxiety is also linked to a greater risk of exacerbations and longer hospital stays.
A Harvard T.H. Chan School of Public Health study projects that China will experience an estimated 65 million COPD deaths and 18 million lung cancer deaths between 2003 and 2033 if current smoking and biomass fuel use levels continue, highlighting the need for large-scale interventions to reduce disease burden
A study finds that eliminating smoking and solid fuel use in China could prevent millions of deaths from chronic diseases. Gradual elimination or moderate-aggressive interventions could avoid 26-31 million COPD deaths and 6.3 million lung cancer deaths by 2033.
Researchers found that cardio-selective beta-blockers significantly reduced mortality in both COPD and non-COPD patients within 30 days of surgery. Long-term mortality reductions were also observed among COPD patients on beta-blockers, with a higher risk of death among those not receiving the medication.
A meta-analysis of randomized trials found that inhaled anticholinergic agents significantly increase the risk of heart attack, stroke, and cardiovascular death by 58% and 80% respectively. The study suggests clinicians closely monitor patients with COPD taking these medications for potential long-term cardiovascular risks.
Researchers found that long-term use of inhaled anticholinergics for COPD increases the risk of cardiovascular death, heart attacks, or strokes by 58%. Patients with COPD who use these inhalers are at high risk of excess serious cardiovascular events.
A new study from Northwestern University's Feinberg School of Medicine found that ipratropium increases the risk of heart attack or arrhythmia by 34% compared to albuterol or no treatment. The study suggests that the medication may have a systemic cardiovascular effect, increasing mortality risk in COPD patients.
Research suggests that eating broccoli may help patients with chronic lung disease by reducing oxidative stress and inflammation. The study found decreased levels of NRF2-dependent antioxidants and increased oxidative stress markers in lungs of smokers with COPD.
A study by Johns Hopkins researchers found that NRF2, a master gene regulating antioxidant and pollutant-detoxifying genes, is significantly decreased in smokers with advanced COPD compared to those without. This discovery could lead to new drug therapies targeting the condition.
The Toward a Revolution in COPD Health (TORCH) study found that combined salmeterol and fluticasone propionate reduced the rate of decline in lung function by 39ml/year, compared to 55ml/year in the placebo group.
A randomized, placebo-controlled study found that creatine supplementation had negligible effects on exercise function in patients with chronic obstructive pulmonary disease (COPD). Despite increased muscle creatine levels, the study's results suggest that physical training alone remains essential for improving outcomes.
Research published in BMC Health Services Research found that only a small minority of eligible elderly patients receive recommended treatments for obstructive respiratory diseases. The study revealed significant disparities in care, including low rates of bronchodilator inhaler use and lung function exams.
A randomized controlled trial found carbocisteine significantly reduced yearly exacerbation rates in Chinese patients with COPD by 25% compared to placebo. This mucolytic drug may be a worthwhile treatment for prevention of exacerbations, particularly in developing countries.
Researchers found that carrying alpha-1 antitrypsin deficiency increases lung cancer risk in smokers and nonsmokers, with the genetic disorder explaining up to 12% of lung cancer patients. Individuals who carry the gene should be screened for lung cancer and avoid potential carcinogens.
A new study found that patients with chronic obstructive pulmonary disease (COPD) who receive low-intensity case management experience significant reductions in emergency room visits and hospitalizations. This simple yet effective model also improves quality of life measures.
The study shows that Perforomist Inhalation Solution delivers bronchodilation comparable to DPI delivery and has similar linear kinetics and excreted drug levels. This offers an effective, long-term treatment option for patients with COPD who may have difficulty coordinating other devices.
A clinical trial found that combining nebulized formoterol fumarate with tiotropium significantly improves dyspnea, COPD symptoms, and rescue medication use. The treatment also shows promise in relieving shortness of breath, chest tightness, and nighttime awakenings.
Researchers found that COPD patients who lived longer than two years obtained more positive results from their PR program than those with end-stage COPD. The study suggests that other factors present at end of life may contribute to poorer outcomes in exercise capacity and quality of life.
A study found that combining nebulized formoterol fumarate with tiotropium significantly improved COPD symptoms, including shortness of breath and chest tightness, in patients. The treatment also showed enhanced control of COPD symptoms, with decreased use of albuterol rescue medication.
Researchers found that markers of oxidative stress were positively associated with declines in lung function five years later. The study used data from the CARDIA cohort and found associations between oxidized LDL and lower lung function in both men and women, but particularly in women.
A Canadian study finds that video-conferencing technology improves pulmonary rehabilitation outcomes for rural patients with chronic obstructive pulmonary disease (COPD). The TELEHEALTH program, which uses video and communications technologies to deliver exercise programs under direct supervision, shows similar results to standard in-p...
Researchers at WashU Medicine have identified a new type of immune response linked to severe asthma and COPD, enabling more precise diagnosis and targeted treatment. The study's findings promise to revolutionize the management of chronic inflammatory lung disease by detecting specific biomarkers in the lungs or bloodstream.
Research found that annual flu vaccines reduced acute respiratory illness and exacerbations of COPD by 67% and 50%, respectively. Patients with severe COPD experienced a 75% reduction in respiratory problems.
Researchers found that COPD patients who used a computer game to control their breathing showed significant improvements in exercise duration and reduced exercise-induced hyperinflation. The study suggests that teaching these breathing techniques to daily activities could greatly improve quality of life for patients.
A study finds that insufficient hydration of the airway surfaces leads to pathologies typical of chronic obstructive lung diseases in humans. This could lead to a new therapeutic strategy for treating asthma and COPD by improving mucus clearance through sodium channel blockers.
Bilateral lung transplantation in younger patients with end-stage COPD provides longer survival than single lung transplantation, with median survival times of 6.41 and 4.59 years, respectively. This finding holds true even after adjusting for pre-transplant characteristics.
Researchers found that black patients with COPD were less likely to receive a lung transplant and more likely to die or be removed from the transplant list than white patients. Despite differences in insurance, socioeconomic status, and cardiovascular risk factors, these disparities persisted.
Researchers at Northwestern University found that high CO2 levels impair lung function and increase the risk of edema. The study suggests reducing CO2 levels to improve treatment outcomes for patients with respiratory distress.
Researchers have discovered that cigarette smoke depletes the Sirtuin (SIRT1) gene, which protects against premature aging and inflammation. Testing antioxidant resveratrol may help restore this gene to prevent lung damage and diseases like COPD and lung cancer.
A recent study found that patients with severe COPD who received salmeterol-fluticasone (SFC) therapy had lower mortality rates compared to those treated with tiotropium. Additionally, SFC treatment was associated with better health status and fewer patient withdrawals.